S&P 500 7,674.48 −1.07%
Nasdaq 26,157.61 −2.04%
S&P/TSX 35,943.02 −1.05%
Apple 345.71 +0.50%
Nvidia 213.46 −3.83%
Microsoft 526.19 −1.27%
Shopify 239.84 −2.08%
Royal Bank 282.81 −0.29%
CAD/USD 0.7131 +0.31%
LIVE · 12:05 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

AURA

Aura Biosciences, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
6.51
+0.05 +0.77%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose AURA in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
ForGrowth III PA B.V. and 2 related5.1%
SCHEDULE 13G · filed Oct 1 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch AURA. Know when insiders buy.
One email the day a filing lands. Free.